Are you Dr. Porter?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 70 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
227 5th Ave Unit B
Kirkland, WA 98033Phone+1 615-346-8182Fax+1 615-829-8970
Summary
- Dr. Douglas Porter, MD is a board certified neurologist in Kirkland, Washington. He is currently licensed to practice medicine in Washington, Minnesota, and Idaho. He is affiliated with Morristown Medical Center, Overlook Medical Center, and East Cooper Medical Center.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Clinical Neurophysiology, 2012 - 2013
MedStar Health/Georgetown University HospitalResidency, Neurology, 2009 - 2012
UMass Chan - BaystateInternship, Internal Medicine, 2008 - 2009
Tufts University School of MedicineClass of 2008
Certifications & Licensure
NM State Medical License 2014 - 2027
DC State Medical License 2009 - 2027
MT State Medical License 2016 - 2026
OH State Medical License 2015 - 2026
NY State Medical License 2014 - 2026
IL State Medical License 2018 - 2026
ID State Medical License 2021 - 2026- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- Join now to see all
Publications & Presentations
PubMed
- 59 citationsDysregulation of the mesolimbic dopamine system and reward in MCH-/- micePavlos Pissios, Lauren E. Frank, Adam R. Kennedy, Douglas R. Porter, Francis E. Marino
Biological Psychiatry. 2008-08-01 - 406 citationsImpaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient miceTohru Kitada, Antonio Pisani, Douglas R. Porter, Hiroo Yamaguchi, Anne Tscherter
Proceedings of the National Academy of Sciences of the United States of America. 2007-07-03 - 151 citationsDJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor.Nan Zhong, Christina Y. Kim, Patrizia Rizzu, Changiz Geula, Douglas R. Porter
The Journal of Biological Chemistry. 2006-07-28
